Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1465-993X
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Inhaled high molecular weight hyaluronan ameliorates respiratory failure in acute COPD exacerbation: a pilot study ; volume:22 ; number:1 ; day:1 ; month:2 ; year:2021 ; pages:1-11 ; date:12.2021
Respiratory research ; 22, Heft 1 (1.2.2021), 1-11, 12.2021

Creator
Galdi, Flavia
Pedone, Claudio
McGee, Christopher A.
George, Margaret
Rice, Annette B.
Hussain, Shah S.
Vijaykumar, Kadambari
Boitet, Evan R.
Tearney, Guillermo J.
McGrath, John A.
Brown, Audrey R.
Rowe, Steven M.
Incalzi, Raffaele A.
Garantziotis, Stavros
Contributor
SpringerLink (Online service)

DOI
10.1186/s12931-020-01610-x
URN
urn:nbn:de:101:1-2021031420033199038680
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:28 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Galdi, Flavia
  • Pedone, Claudio
  • McGee, Christopher A.
  • George, Margaret
  • Rice, Annette B.
  • Hussain, Shah S.
  • Vijaykumar, Kadambari
  • Boitet, Evan R.
  • Tearney, Guillermo J.
  • McGrath, John A.
  • Brown, Audrey R.
  • Rowe, Steven M.
  • Incalzi, Raffaele A.
  • Garantziotis, Stavros
  • SpringerLink (Online service)

Other Objects (12)

COPD exacerbation: Lost in translation

COPD exacerbation: Lost in translation

Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease

Effects of inhaled high-molecular weight hyaluronan in inflammatory airway disease

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?

COPD patients prescribed inhaled corticosteroid in primary care: time for re-assessment based on exacerbation rate and blood eosinophils?

Blood and sputum eosinophilia in COPD exacerbation

Blood and sputum eosinophilia in COPD exacerbation

Handgrip strength during admission for COPD exacerbation: impact on further exacerbation risk

Handgrip strength during admission for COPD exacerbation: impact on further exacerbation risk

Effectiveness of inhaled furosemide for acute asthma exacerbation: a meta-analysis

Effectiveness of inhaled furosemide for acute asthma exacerbation: a meta-analysis

Reversibility of Hypercapnia after an Acute Exacerbation of COPD

Reversibility of Hypercapnia after an Acute Exacerbation of COPD

Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)

Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)

Tako-Tsubo-Cardiomyopathie bei COPD-Exacerbation, Pneumothorax und Lungen-Karzinom

Tako-Tsubo-Cardiomyopathie bei COPD-Exacerbation, Pneumothorax und Lungen-Karzinom

Predictors of outcome of noninvasive ventilation in severe COPD exacerbation

Predictors of outcome of noninvasive ventilation in severe COPD exacerbation

Aspergillus fumigatus during COPD exacerbation: a pair-matched retrospective study

Aspergillus fumigatus during COPD exacerbation: a pair-matched retrospective study

Fluticasone Furoate/Umeclidinium/Vilanterol Initiation Following a COPD Exacerbation: Benefits of Prompt Initiation on COPD Outcomes

Fluticasone Furoate/Umeclidinium/Vilanterol Initiation Following a COPD Exacerbation: Benefits of Prompt Initiation on COPD Outcomes

Related objects